JASCAYD® (nerandomilast)

Published: October 10, 2025 in Drug

Full Name	JASCAYD® (nerandomilast)
Drug	nerandomilast
Manufacturer	Boehringer Ingelheim
Route of Administration	Oral
Site of Care	Home
Approved Indication	The treatment of idiopathic pulmonary fibrosis in adult patients The treatment of progressive pulmonary fibrosis in adult patients
Disease	Idiopathic pulmonary fibrosis (IPF); Progressive pulmonary fibrosis (PPF)
Therapeutic Area	Pulmonology
Enrollment Form Link	Enrollment Form
Phone Number	847-239-5646
Fax Number	847-423-6217
Product Website	jascayd.com